Evidence map›Paper›PMID 40637372›Full record

ArticleMicrobial genomics2025

Enhancing public health surveillance: a comparative study of platform-specific and hybrid assembly approaches in SARS-CoV-2 genome sequencing.

Yasemin Coşgun, Süleyman Yalçın, Ege Dedeoğlu, Gültekin Ünal, Katharina Kopp, Biran Musul, Ekrem Sağtaş, Philomena Raftery, Gülay Korukluoğlu, Sedat Kaygusuz

Abstract readComparative Study
In one paragraph

Article in Microbial genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yasemin CoşgunThe National Virology Reference Laboratory, Public Health General Directorate, Ministry of Health, Ankara, Türkiye.
Süleyman YalçınThe Department of National Reference Laboratories and Biological Products, Public Health General Directorate, Ministry of Health, Ankara, Türkiye.
Ege DedeoğluWorld Health Organization Country Office in Türkiye, Ankara, Türkiye.
Gültekin ÜnalWorld Health Organization Country Office in Türkiye, Ankara, Türkiye.
Katharina KoppWorld Health Organization Country Office in Türkiye, Ankara, Türkiye, from January 2022 to May 2023.
Biran MusulWorld Health Organization Country Office in Türkiye, Ankara, Türkiye.
Ekrem SağtaşThe Department of National Reference Laboratories and Biological Products, Public Health General Directorate, Ministry of Health, Ankara, Türkiye.
Philomena RafteryWorld Health Organization Country Office in Türkiye, Ankara, Türkiye.
Gülay KorukluoğluThe National Virology Reference Laboratory, Public Health General Directorate, Ministry of Health, Ankara, Türkiye.
Sedat KaygusuzPublic Health General Directorate, Ministry of Health, Ankara, Türkiye.

Funding

World Health Organization 001
6 · The paper itself

Abstract

During the COVID-19 pandemic, next-generation sequencing (NGS) has been instrumental for public health laboratories in tracking severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutations and informing responses. Illumina systems and Oxford Nanopore Technologies (ONT) have been primary tools for NGS, each presenting unique advantages. The hybrid assembly (HA) approach, integrating short- and long-read sequencing methods, has been developed to improve genome accuracy by utilizing the combined advantages of both techniques. While HA has been used to enhance SARS-CoV-2 genome quality, its optimal applications for SARS-CoV-2 sequencing and surveillance have not been systematically studied. This study seeks to address this gap by evaluating the conditions under which HA improves SARS-CoV-2 genomic surveillance, analysing 192 samples using eight bioinformatics methods across both platforms. HA was evaluated against single-technology approaches for its genome assembly and mutation detection performance. While HA did not outperform single-technology methods in detecting unique mutations, it produced marginally more complete genomes than Illumina-based methods. Importantly, mutations identified by HA were consistently detected across all eight methodologies, demonstrating its reliability in mutation detection. Moreover, our research underlines the critical need for in-house validation of methods and exposes the limitations inherent in proprietary pipelines. Our findings suggest that an HA approach could be used as a quality control tool in genomic surveillance, particularly for improving low-quality ONT sequencing data by integrating high-quality Illumina sequencing data. However, implementing HA demands the presence of both sequencing platforms and additional resources, such as hands-on time, expensive sequencing reagents and bioinformatics know-how. A decision-tree analysis identified the percentage of trimmed ONT reads relative to total reads as crucial for HA success, emphasizing the significance of high-quality ONT reads. This comprehensive approach provides public health laboratories insights to refine genomic surveillance strategies for SARS-CoV-2, potentially influencing future research and response efforts.

Indexed as

COVID-19Genome, ViralHigh-Throughput Nucleotide SequencingPublic Health SurveillanceSARS-CoV-2Computational BiologyHumansMutationWhole Genome Sequencinggenomic surveillancehybrid assemblyIlluminaOxford Nanopore TechnologiesSARS-CoV-2

Identifiers

PMID40637372
PMCPMC12244368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.